SCHEMBL404750

SCHEMBL404750

O=C(O)c1ccc(F)cc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.53
ATM Q13315 1/20 0.53
DTYMK P23919 1/20 0.49
KCNMA1 Q12791 1/20 0.48
KEAP1 Q14145 1/20 0.47
TSHR P16473 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
ALOX15 P16050 1/20 0.46
CASP6 P55212 1/20 0.46
CES2 O00748 2/20 0.44
PDE7A Q13946 1/20 0.43
TTR P02766 1/20 0.43
CES1 P23141 1/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
RXRA P19793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL26110373 0.98 TDP1 (0.52) TDP1ATMDTYMKKCNMA1KEAP1
SCHEMBL5196091 0.86 BCL2L1 (0.46) TDP1ATMDTYMKKCNMA1TSHR
SCHEMBL357813 0.85 DTYMK (0.62) TDP1ATMDTYMKKCNMA1KEAP1
SCHEMBL621197 0.84 TDP1 (0.52) TDP1ATMKCNMA1ALDH1A1CES2
SCHEMBL404749 0.84 ATM (0.52) TDP1ATMKCNMA1ALDH1A1CYP3A4
SCHEMBL4817687 0.84 ATM (0.52) TDP1ATMKCNMA1TSHRALDH1A1
SCHEMBL28438281 0.84 DTYMK (0.60) TDP1ATMDTYMKKCNMA1KEAP1
SCHEMBL12394315 0.83 TTR (0.59) TDP1ATMALDH1A1CES2TTR
SCHEMBL5195739 0.82 DCLRE1B (0.56) TDP1KCNMA1TSHR
SCHEMBL6998567 0.82 ATM (0.50) TDP1ATMKCNMA1ALDH1A1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117567346-B Bismaleimide and preparation method thereof, and method for preparing aviation heat-resistant die plate 重庆渝启欣科技发展有限公司 2024-10-29 CN claimed
CN-114213202-B Preparation method of 2, 4-substituted benzoic acid 石河子大学 2024-07-05 CN claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
CN-115974812-B Fluorescent probe for nondestructive monitoring of fish freshness and preparation method and application thereof 渤海大学 2024-03-08 CN claimed
CN-117567346-A Bismaleimide and preparation method thereof, and method for preparing aviation heat-resistant die plate 重庆渝启欣科技发展有限公司 2024-02-20 CN claimed
CN-116410159-B Preparation method and application of En Qu Ti-Ni intermediate 济南国鼎医药科技有限公司 2023-08-22 CN claimed
CN-116410159-A Preparation method and application of En Qu Ti-Ni intermediate 济南国鼎医药科技有限公司 2023-07-11 CN claimed
CN-115974812-A Fluorescent probe for nondestructive monitoring of fish freshness and preparation method and application thereof 渤海大学 2023-04-18 CN claimed
CN-114213202-A Preparation method of 2, 4-substituted benzoic acid 石河子大学 2022-03-22 CN claimed
CN-106187803-A The synthetic method of the amides compound that a kind of phosphorus oxychloride promotes 中国人民解放军63975部队 2016-12-07 CN claimed
WO-2014111493-A1 SUBSTITUTED BENZIMIDAZOLYL PHOSPHINE COMPOUNDS AND A METHOD FOR DECARBOXYLATING CARBON-CARBON LINKING SALTIGO GMBH (DE) 2014-07-24 WO claimed
EP-2757106-A1 Substituted benzimidazole phosphine compounds and a method for decarboxylating carbon-carbon bond Saltigo GmbH (DE) 2014-07-23 EP claimed
CN-101932557-A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof GLAXOSMITHKLINE LLC 2010-12-29 CN claimed
US-20100305207-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF GLAXOSMITHKLINE LLC 2010-12-02 US claimed
EP-2195287-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF GlaxoSmithKline LLC (US) 2010-06-16 EP claimed
WO-2009045830-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2009-04-09 WO claimed
EP-4736882-A2 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE Cullgen (Shanghai), Inc. (CN) 2026-05-06 EP disclosed
EP-3841098-B1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE CULLGEN SHANGHAI INC (CN) 2026-01-14 EP disclosed
US-4075346-A CNS depressant γ-(secondary amino)-ortho-nitro-butyrophenones SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-02-21 US disclosed
US-4031226-A ANTIEMETIC, PSYCHOTROPIC JANSSEN PHARMACEUTICA N.V. (BE) 1977-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305207-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF PYGM, PYGL, G6PC1 TDP1 803/4885ATM 1531/4885DTYMK 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.